"Backed by interim overall survival data showing a strong favourable trend compared to osimertinib, we believe strongly in the robust efficacy and safety of Rybrevant – both as a standalone ...
When the IBM PC was new, I served as the president of the San Francisco PC User Group for three years. That’s how I met PCMag’s editorial team, who brought me on board in 1986. In the years ...